关注
Kankana Bardhan
Kankana Bardhan
Seres Therapeutics
在 serestherapeutics.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
N Patsoukis, K Bardhan, P Chatterjee, D Sari, B Liu, LN Bell, ED Karoly, ...
Nature communications 6 (1), 6692, 2015
11092015
The PD1: PD-L1/2 pathway from discovery to clinical implementation
K Bardhan, T Anagnostou, VA Boussiotis
Frontiers in immunology 7, 550, 2016
5962016
Epigenetics and colorectal cancer pathogenesis
K Bardhan, K Liu
Cancers 5 (2), 676-713, 2013
3232013
NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression
F Liu, K Bardhan, D Yang, M Thangaraju, V Ganapathy, JL Waller, ...
Journal of Biological Chemistry 287 (30), 25530-25540, 2012
1792012
Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo
D Yang, CM Torres, K Bardhan, M Zimmerman, TL McGaha, K Liu
The Journal of Immunology 188 (9), 4441-4449, 2012
1072012
Corrigendum: Regulation of T Cell Differentiation and Function by EZH2
BVA Karantanos T, Christofides A, Bardhan K, Li L
front immunol 7, 172, 2016
992016
Clinical significance of T cell metabolic reprogramming in cancer
C Herbel, N Patsoukis, K Bardhan, P Seth, JD Weaver, VA Boussiotis
Clinical and translational medicine 5, 1-23, 2016
952016
GCN2-dependent metabolic stress is essential for endotoxemic cytokine induction and pathology
H Liu, L Huang, J Bradley, K Liu, K Bardhan, D Ron, AL Mellor, DH Munn, ...
Molecular and cellular biology 34 (3), 428-438, 2014
872014
Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer
X Hu, K Bardhan, AV Paschall, D Yang, JL Waller, MA Park, ...
Journal of Biological Chemistry 288 (26), 19103-19115, 2013
782013
Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.
BVA Christofides A, Karantanos T, Bardhan K
oncotarget, 2016
602016
Acquired resistance of EGFR-mutated lung cancer to tyrosine kinase inhibitor treatment promotes PARP inhibitor sensitivity
L Marcar, K Bardhan, L Gheorghiu, P Dinkelborg, H Pfäffle, Q Liu, ...
Cell reports 27 (12), 3422-3432. e4, 2019
592019
IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation
AV Paschall, R Zhang, CF Qi, K Bardhan, L Peng, G Lu, J Yang, M Merad, ...
The Journal of Immunology 194 (5), 2369-2379, 2015
562015
IFNγ induces DNA methylation–silenced GPR109A expression via pSTAT1/p300 and H3K18 acetylation in colon cancer
K Bardhan, AV Paschall, D Yang, MR Chen, PS Simon, YD Bhutia, ...
Cancer immunology research 3 (7), 795-805, 2015
452015
The role of metabolic reprogramming in T cell fate and function
N Patsoukis, K Bardhan, J Weaver, C Herbel, P Seth, L Li, VA Boussiotis
Current trends in immunology 17, 1, 2016
442016
Lymphotoxin β receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of …
X Hu, MA Zimmerman, K Bardhan, D Yang, JL Waller, GB Liles, JR Lee, ...
Carcinogenesis 34 (5), 1105-1114, 2013
402013
The PD‐1 Interactome
Q Wang, K Bardhan, VA Boussiotis, N Patsoukis
Advanced biology 5 (9), 2100758, 2021
332021
Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
K Bardhan, HI Aksoylar, T Le Bourgeois, L Strauss, JD Weaver, B Delcuze, ...
Scientific reports 9 (1), 17252, 2019
322019
The PD1: PD-L1/2 pathway from discovery to clinical implementation. Front Immunol. 2016; 7: 550
K Bardhan, T Anagnostou, VA Boussiotis
Epub 2016/12/27. https://doi. org/10.3389/fimmu. 2016.00550 PMID: 28018338, 2016
312016
The adaptor molecule RIAM integrates signaling events critical for integrin-mediated control of immune function and cancer progression
N Patsoukis, K Bardhan, JD Weaver, D Sari, A Torres-Gomez, L Li, ...
Science signaling 10 (493), eaam8298, 2017
302017
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun 6: 6692
N Patsoukis, K Bardhan, P Chatterjee, D Sari, B Liu, LN Bell, ED Karoly, ...
Immunity 38, 633-643, 2015
282015
系统目前无法执行此操作,请稍后再试。
文章 1–20